Search for a report

EUROPE AMNIOTIC MEMBRANE MARKET FORECAST 2022-2030

  • You are here:
  • Home
  • Downloads
  • EUROPE AMNIOTIC MEMBRANE MARKET FORECAST 2022-2030

EUROPE AMNIOTIC MEMBRANE MARKET FORECAST 2022-2030

The Europe amniotic membrane market is expected to project a CAGR of 6.92% during the forecast period, 2022-2030, and is set to generate a revenue share of $666.20 million by 2030.

EUROPE AMNIOTIC MEMBRANE MARKET FORECAST 2022-2030

Europe Amniotic Membrane Market by Product (Cryopreserved Amniotic Membrane, Lyophilization Amniotic Membrane) Market by Application (Surgical Wounds, Ophthalmology, Other Applications) Market by End-users (Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Research Centers & Laboratories) by Geography

Request free sample

The Europe amniotic membrane market is expected to project a CAGR of 6.92% during the forecast period, 2022-2030, and is set to generate a revenue share of $666.20 million by 2030.

The target population for amniotic membrane use is rising in the region. Also, HAM (human amniotic membrane) is vastly used in soft tissue engineering in decellularized and fresh from. In this regard, the National Library of Medicine, London, has been working on this study in the past decade.

Europe Amniotic Membrane Market

To know more about this report, request a free sample copy

The Europe amniotic membrane market growth evaluation includes the analysis of Germany, the United Kingdom, France, Poland, Belgium, Russia, Italy, and Rest of Europe. Europe’s major proportion of R&D with regard to the amniotic membrane (AM) is centered in the United Kingdom. Also, several hospital chains like NuVision offer AM treatments in ophthalmology. In addition, advancements in science and technological instruments have increased the popularity of AM treatments.

In France, many hospitals offer AM transplants and treatments. For instance, La Clinique de l’Infirmerie Protestante has made several advancements in surgeries and has been certified by the National Health Authority (HAS). Also, AM transplants are used for oral therapy in the country. Additionally, several human tissue banks in the country preserve AM from donors.

In Belgium, the rising technological advancements and the use of AM for wound healing and skin & bone transplantation contribute to market growth. Though there are fewer casualties of high intensity in the country, there are a number of hospitals that work in AM transplantation. For instance, Antwerp University Hospital (UZA) is a university clinic associated with the fully accredited and publicly-funded University of Antwerp.

The report scope of the Europe amniotic membrane market includes the segmentation assessment of product, end-users, and application. The application segment includes ophthalmology, surgical wounds, and other applications. With regard to chronic wounds’ healing, the process gets stuck at the proliferative or inflammatory phase. This is prevalent in large wounds with significant tissue loss that do not epithelialize and become senescent. As a result, doctors need to eliminate the factors that delay or prevent normal wound healing. Hence, lyophilized amniotic membrane (LAM) is used to treat such wounds for good results.

Further, AM’s unique properties have enabled its use for varied applications. These include disorders associated with the oral cavity, urinary tract, head and neck, pelvic and abdominal surgery, artificial vaginal reconstruction, stomach, urinary tract, and skin. In certain cases, non-biological or other biological components are coated on the AM to enhance its performance and properties.

Some of the eminent companies in the Europe amniotic membrane market are Integra LifeSciences Corp, Surgenex Llc, Human Regenerative Technologies, Labtician Ophthalmics Inc, etc.

Integra LifeSciences is a global leader in medical technology. It offers advanced solutions in general, reconstructive surgery, orthopedic extremity surgery, and neurosurgery advanced wound management. Additionally, it offers innovative healthcare solutions through 50 offices in over 130 countries, with headquarters in Princeton, New Jersey, United States.

One of its key products, Integra Bilayer Wound Matrix, is an enhanced wound care device with a porous matrix of cross-linked bovine tendon collagen. It facilitates an ideal environment to supplement cellular repopulation and revascularization processes central to wound healing.

Report Synopsis

Report Scope Details
Market Forecast Years 2022-2030
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue (Million)
Segments Analyzed Product, Applications, End-Users
Countries Analyzed Germany, the United Kingdom, France, Poland, Belgium, Russia, Italy, and Rest of Europe
Companies Analyzed Amino Technology Llc, Amino X Medical Inc, Bio-Tissue Inc, Celularity Inc, Human Regenerative Technologies, Integra LifeSciences Corp, Katena Products Inc, Labtician Ophthalmics Inc, MiMedx, Organogenesis Inc, Skye Biologics Llc, Smith & Nephew Plc, Stryker Corporation, Surgenex Llc, SurgiLogix Llc

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • RISING INCIDENTS OF BURN INJURIES AND TRAUMATIC WOUNDS
        • INCREASING RESEARCH ON STEM CELL BIOLOGY AND REGENERATIVE MEDICINE
        • AWARENESS PROGRAMS FOR WOUND CARE TREATMENT
      • KEY RESTRAINTS
        • LIMITATIONS ASSOCIATED WITH USE OF AMNIOTIC MEMBRANE
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON AMNIOTIC MEMBRANE MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRANTS
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY PRODUCT
      • CRYOPRESERVED AMNIOTIC MEMBRANE
      • LYOPHILIZATION AMNIOTIC MEMBRANE
    3. MARKET BY APPLICATION
      • SURGICAL WOUNDS
      • OPHTHALMOLOGY
      • OTHER APPLICATIONS
    4. MARKET BY END-USERS
      • HOSPITALS
      • AMBULATORY SURGICAL CENTERS
      • SPECIALIZED CLINICS
      • RESEARCH CENTERS & LABORATORIES
    5. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
      • COMPANY PROFILES
        • AMINO TECHNOLOGY LLC
        • AMINO X MEDICAL INC
        • BIO-TISSUE INC
        • CELULARITY INC
        • HUMAN REGENERATIVE TECHNOLOGIES
        • INTEGRA LIFESCIENCES CORP
        • KATENA PRODUCTS INC
        • LABTICIAN OPHTHALMICS INC
        • MIMEDX
        • ORGANOGENESIS INC
        • SKYE BIOLOGICS LLC
        • SMITH & NEPHEW PLC
        • STRYKER CORPORATION
        • SURGENEX LLC
        • SURGILOGIX LLC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – AMNIOTIC MEMBRANE

    TABLE 2: EUROPE AMNIOTIC MEMBRANE MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 3: EUROPE AMNIOTIC MEMBRANE MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 4: EUROPE AMNIOTIC MEMBRANE MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 5: EUROPE AMNIOTIC MEMBRANE MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 6: EUROPE AMNIOTIC MEMBRANE MARKET, BY END-USERS, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 7: EUROPE AMNIOTIC MEMBRANE MARKET, BY END-USERS, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 8: EUROPE AMNIOTIC MEMBRANE MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

    TABLE 9: EUROPE AMNIOTIC MEMBRANE MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

    TABLE 10: LEADING PLAYERS OPERATING IN EUROPE AMNIOTIC MEMBRANE MARKET

    TABLE 11: ROAD ACCIDENTS IN BELGIUM IN 2019-2020

    TABLE 12: LIST OF MERGERS & ACQUISITIONS

    TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS                                                

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: EUROPE AMNIOTIC MEMBRANE MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021

    FIGURE 6: EUROPE AMNIOTIC MEMBRANE MARKET, BY CRYOPRESERVED AMNIOTIC MEMBRANE, 2022-2030 (IN $ MILLION)

    FIGURE 7: EUROPE AMNIOTIC MEMBRANE MARKET, BY LYOPHILIZATION AMNIOTIC MEMBRANE, 2022-2030 (IN $ MILLION)

    FIGURE 8: EUROPE AMNIOTIC MEMBRANE MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021

    FIGURE 9: EUROPE AMNIOTIC MEMBRANE MARKET, BY SURGICAL WOUNDS, 2022-2030 (IN $ MILLION)

    FIGURE 10: EUROPE AMNIOTIC MEMBRANE MARKET, BY OPHTHALMOLOGY, 2022-2030 (IN $ MILLION)

    FIGURE 11: EUROPE AMNIOTIC MEMBRANE MARKET, BY OTHER APPLICATIONS, 2022-2030 (IN $ MILLION)

    FIGURE 12: EUROPE AMNIOTIC MEMBRANE MARKET, GROWTH POTENTIAL, BY END-USERS, IN 2021

    FIGURE 13: EUROPE AMNIOTIC MEMBRANE MARKET, BY HOSPITALS, 2022-2030 (IN $ MILLION)

    FIGURE 14: EUROPE AMNIOTIC MEMBRANE MARKET, BY AMBULATORY SURGICAL CENTERS, 2022-2030 (IN $ MILLION)

    FIGURE 15: EUROPE AMNIOTIC MEMBRANE MARKET, BY SPECIALIZED CLINICS, 2022-2030 (IN $ MILLION)

    FIGURE 16: EUROPE AMNIOTIC MEMBRANE MARKET, BY RESEARCH CENTERS & LABORATORIES, 2022-2030 (IN $ MILLION)

    FIGURE 17: EUROPE AMNIOTIC MEMBRANE MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

    FIGURE 18: UNITED KINGDOM AMNIOTIC MEMBRANE MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 19: GERMANY AMNIOTIC MEMBRANE MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 20: FRANCE AMNIOTIC MEMBRANE MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 21: ITALY AMNIOTIC MEMBRANE MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 22: NUMBER OF DONATIONS OF AMNIOTIC MEMBRANE IN ITALY, 2016-2020

    FIGURE 23: RUSSIA AMNIOTIC MEMBRANE MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 24: BELGIUM AMNIOTIC MEMBRANE MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 25: POLAND AMNIOTIC MEMBRANE MARKET, 2022-2030 (IN $ MILLION)

    FIGURE 26: REST OF EUROPE AMNIOTIC MEMBRANE MARKET, 2022-2030 (IN $ MILLION)       

    1. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • UNITED KINGDOM
          • GERMANY
          • FRANCE
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. MARKET BY PRODUCT
      • CRYOPRESERVED AMNIOTIC MEMBRANE
      • LYOPHILIZATION AMNIOTIC MEMBRANE
    2. MARKET BY APPLICATION
      • SURGICAL WOUNDS
      • OPHTHALMOLOGY
      • OTHER APPLICATIONS
    3. MARKET BY END-USERS
      • HOSPITALS
      • AMBULATORY SURGICAL CENTERS
      • SPECIALIZED CLINICS
      • RESEARCH CENTERS & LABORATORIES

    To request a free sample copy of this report, please complete the form below :

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type

      Buy Now